These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35192858)

  • 1. Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of Polysorbates.
    Wuchner K; Yi L; Chery C; Nikels F; Junge F; Crotts G; Rinaldi G; Starkey JA; Bechtold-Peters K; Shuman M; Leiss M; Jahn M; Garidel P; de Ruiter R; Richer SM; Cao S; Peuker S; Huille S; Wang T; Le Brun V
    J Pharm Sci; 2022 May; 111(5):1280-1291. PubMed ID: 35192858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the Future.
    Wuchner K; Yi L; Chery C; Nikels F; Junge F; Crotts G; Rinaldi G; Starkey JA; Bechtold-Peters K; Shuman M; Leiss M; Jahn M; Garidel P; de Ruiter R; Richer SM; Cao S; Peuker S; Huille S; Wang T; Brun VL
    J Pharm Sci; 2022 Nov; 111(11):2955-2967. PubMed ID: 36002077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
    Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for the Use of Polysorbates in Biopharmaceuticals.
    Jones MT; Mahler HC; Yadav S; Bindra D; Corvari V; Fesinmeyer RM; Gupta K; Harmon AM; Hinds KD; Koulov A; Liu W; Maloney K; Wang J; Yeh PY; Singh SK
    Pharm Res; 2018 May; 35(8):148. PubMed ID: 29797101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
    Tomlinson A; Zarraga IE; Demeule B
    Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends on Analytical Characterization of Polysorbates and Their Degradation Products in Biopharmaceutical Formulations.
    Martos A; Koch W; Jiskoot W; Wuchner K; Winter G; Friess W; Hawe A
    J Pharm Sci; 2017 Jul; 106(7):1722-1735. PubMed ID: 28302541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.
    Dwivedi M; Buske J; Haemmerling F; Blech M; Garidel P
    Eur J Pharm Sci; 2020 Mar; 144():105211. PubMed ID: 31931121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products.
    Zhang S; Xiao H; Goren M; Burakov D; Chen G; Li N; Tustian A; Adams B; Mattila J; Bak H
    J Pharm Sci; 2020 Sep; 109(9):2710-2718. PubMed ID: 32534029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of the Water Evaporation Rate and Saccharide Excipients on the Oxidative Degradation of Polysorbates During Oven Drying and Spray Drying.
    Pinto JT; Rajkovaca M; Paudel A
    J Pharm Sci; 2023 Jan; 112(1):36-39. PubMed ID: 36334810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of polysorbates 20 and 80 catalysed by histidine chloride buffer.
    Brovč EV; Mravljak J; Šink R; Pajk S
    Eur J Pharm Biopharm; 2020 Sep; 154():236-245. PubMed ID: 32693155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection.
    Evers DH; Schultz-Fademrecht T; Garidel P; Buske J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122287. PubMed ID: 33069954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method.
    Honemann MN; Wendler J; Graf T; Bathke A; Bell CH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1116():1-8. PubMed ID: 30951966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases.
    Zhang S; Riccardi C; Kamen D; Reilly J; Mattila J; Bak H; Xiao H; Li N
    Pharm Res; 2022 Jan; 39(1):75-87. PubMed ID: 34981317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation.
    Li X; Wang F; Li H; Richardson DD; Roush DJ
    Antib Ther; 2022 Jan; 5(1):42-54. PubMed ID: 35155990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
    Kerwin BA
    J Pharm Sci; 2008 Aug; 97(8):2924-35. PubMed ID: 17973307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics.
    Kishore RS; Kiese S; Fischer S; Pappenberger A; Grauschopf U; Mahler HC
    Pharm Res; 2011 May; 28(5):1194-210. PubMed ID: 21369824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled polysorbate 20 hydrolysis - A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time.
    Graf T; Abstiens K; Wedekind F; Elger C; Haindl M; Wurth C; Leiss M
    Eur J Pharm Biopharm; 2020 Jul; 152():318-326. PubMed ID: 32445968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edetate Disodium as a Polysorbate Degradation and Monoclonal Antibody Oxidation Stabilizer.
    Yarbrough M; Hodge T; Menard D; Jerome R; Ryczek J; Moore D; Baldus P; Warne N; Ohtake S
    J Pharm Sci; 2019 Apr; 108(4):1631-1635. PubMed ID: 30502482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations.
    Katz JS; Chou DK; Christian TR; Das TK; Patel M; Singh SN; Wen Y
    J Pharm Sci; 2022 Apr; 111(4):919-932. PubMed ID: 34883096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of Biologics and the Quest for Polysorbate Alternatives.
    Dubey S; Giovannini R
    Trends Biotechnol; 2021 Jun; 39(6):546-549. PubMed ID: 33139073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.